Explore the BIO Digital 2021 Sessions below.
Get inside the CEO’s brain during this one-on-one conversation with Dr. Albert Bourla,…
Reliable and in-depth business development intelligence is critical to sustaining biopharma…
One Health, or the concept that animal, human, and environmental health are interconnected, has…
In 2020, vaccine developers moved swiftly to find COVID-19 vaccine candidates, using pioneering…
The COVID-19 pandemic has highlighted the critical public health role for rapid, accurate and…
David Thomas, CFA, Vice President, Industry Research will provide an update on the COVID…
Curious about federal policy on AMR and how you can be heard? Join this session to learn about…
Machine learning has the potential to help scientists transform several elements of disease…
Dr. Chantal Vogels is an Associate Research Scientist in the Department of Epidemiology of…
We have been starkly reminded that infectious disease pandemics are very costly to society - but…
The COVID-19 pandemic has shown us that it is possible to speed up clinical trials. …
Infectious diseases like to travel and they often do so incognito with no passports required,…
In the current environment, nascent biotech companies can raise funding from a variety of…
Data and evidence are important – but in the era of alternative facts, they may not matter…
Ending the HIV/AIDS epidemic is possible through continued innovation – but unwavering…
With a 175% increase in announced SPAC M&As for biopharma deals between 2019 and 2020, it…
When COVID‐19 initially emerged, the narrative was that children were spared and the focus…
The onset of COVID-19 required rapid development and availability of potential treatments. …
Vaccines have gone from under the radar to everywhere in the mind of the public and many new…
IPOs and after-market performance have continued at a breakneck pace. The influx of investor…
Patients, policymakers, and payors continue to look toward health technology assessment (HTA) as…
How we conduct clinical trials has been evolving as a result of new technologies and tools …
Dealmakers adjusted to the new landscape of remote work and navigating a global health crisis in…
Karen Heichman, PhD has been at the Bill & Melinda Gates Foundation since July 2018, where…
Thomas joined Sanofi Pasteur in 2004 and has since advanced within the company in several roles…
The pandemic forced support ecosystems for emerging biotechs to adapt their processes to…
Join Dr. Jeremy Levin, Chairman of the Board and CEO of Ovid Therapeutics for a conversation…
This interactive and practical program will focus on the ongoing impact of the pandemic on…
Commercialization was once considered the last mile for any digital medicine company or…
The IPO Class has grown over the last 8 years and continued through a COVID-19 inflection. This…
The COVID-19 pandemic has exposed vulnerabilities and inequities throughout society, including…
Innovative collaborations increasingly play a vital role in ensuring that the latest scientific…
Gene therapies are transforming patients’ lives in ways unimaginable 20 years ago&mdash…
Collaboration among industry stakeholders is essential to discovering and developing emerging I…
What we eat and how we access food is transforming and investment trends in food and ag tech…
Peter serves as CGO, combining clinical and medical understanding in genetic testing with an…
Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes of…
Now more than ever, science is entering the public consciousness – from Covid-19 to…
People living with a rare disease or condition not only face unique medical challenges in living…
Over the past five years, Horizon Therapeutics has transformed into a leading, large cap,…
Patients are more involved in their healthcare decision-making today than ever before, and are…
For over a decade now, the patient’s journey through the healthcare system has been…
The coronavirus has exposed how deeply vulnerable modern society and the global economy can be…
This event brings together thought leaders from the across the biotechnology ecosystem to share…
The Biotechnology Heritage Award is co-presented by The Biotechnology Innovation Organization …
BIO, in partnership with Coqual, is launching the second-annual Measuring Diversity and…
Over the past year and a half, vaccines and diagnostics research aimed at stopping the spread of…
Dr. Jennifer Holmgren is the Chief Executive Officer of LanzaTech. Jennifer has over 20 years of…
Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo is a synthetic biology…
Duane Schultess will review Vital Transformation’s new research analyzing the impact of H…
Alan Shaw, Ph.D., is President, Chief Executive Officer and Co-Founder of Calysta, and a member…
In an age of crisis, can the biopharma industry withstand global shocks?
2020 revealed…
Companies, investors, and shareholders have business imperatives to ensure boards reflect the…
Current federal and state reimbursement systems are not nimble enough to accommodate the pace of…
Advances in biotechnology innovation have had a vital impact on the U.S. economy — life…
As an early pioneer in the high-throughput synthesis and sequencing of DNA, Dr. Leproust is…
One of the pillars of the BIOEquality Agenda is expanding opportunities in the industry for…
Safety concerns about COVID-19 have led many patients to delay routine healthcare screenings,…
In this panel, learn ways to accelerate post-discovery to IND milestone timelines leading to…
The COVID-19 pandemic – and scientific and technological advancements – have made…
